Roche
Search results
Novartis is a global pharmaceutical company that develops innovative medicines to address society’s greatest disease burdens. Learn about its science, impact, news and career opportunities.
- Careers
Search for careers at Novartis and discover our diverse and...
- Contacts
Contacts - Novartis
- About
Learn more about Novartis and explore our core therapeutic...
- News
News - Novartis
- Clinical Trials
Novartis believes one aspect of building trust with society...
- Partnering
Partnering - Novartis
- Supplier Portal
Supplier Portal - Novartis
- Report side effects
Novartis o sus agentes podrán contactar con usted para...
- Careers
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. [4] [5]
Novartis is a leading innovative medicines company that aims to improve the lives of people living with disease. Explore our business functions, opportunities, benefits, stories and join our talent community.
Browse the list of Novartis products by active ingredient, therapeutic area and availability in different countries. Learn about the innovative and diverse Novartis global product portfolio and its applications.
Novartis Healthcare Philippines, Inc. incorporated in 1996 is one of the leading research-based pharmaceutical companies in the country, providing innovative, life-saving medicines to patients. Novartis has made substantial contributions to support the Philippine economy and improve health outcomes of Filipinos:
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are...
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
